Partner Hospitals

Founded in 1920. It is the supporting institution for the National Center for Stomatology and the National Clinical Research Center for Oral Diseases. Its Department of Plastic and Reconstructive Surgery remains the world’s largest plastic surgery medical center and China’s leading center for plastic surgery in medical treatment, teaching and research. Annual outpatient and emergency visits exceed 4.8 million, inpatient admissions over 150,000, inpatient surgeries more than 90,000, and outpatient surgical procedures over 170,000.

Founded in 1957, it is China’s first Grade A tertiary specialized hospital focusing on the diagnosis and treatment of cardiothoracic diseases after the founding of the People’s Republic of China. Centered on two major discipline clusters: thoracic tumors and cardiovascular diseases, it masters the most extensive spectrum and full range of diagnostic and therapeutic technologies for cardiothoracic diseases in China. Annual outpatient and emergency visits exceed 860,000, with more than 28,000 surgeries performed each year. The proportion of Grade-III and Grade-IV surgeries is over 90%. Its surgical volume for tracheal and mediastinal tumors ranks No.1 nationwide, lung tumor surgery volume ranks No.2 nationwide, and esophageal surgery volume is among the top in China and ranks No.1 in the city.

Founded in 1921, it is one of the earliest hospitals tasked with providing medical services for foreign guests. Annual surgeries exceed 70,000, and annual inpatient admissions are over 120,000. It hosts 6 national-level research platforms, including the National Key Laboratory for Severe, Complex and Rare Diseases, the National Major Science and Technology Infrastructure for Translational Medicine, the National Clinical Research Center for Obstetric and Gynecologic Diseases, and the National Clinical Research Center for Skin and Immune Diseases.

Founded in 1892, it is China’s first medical institution certified as an International Comprehensive Stroke Center by the World Stroke Organization. Specialties including rheumatology and immunology, orthopedics, obstetrics and gynecology, endocrinology and neurology rank among the top in China. It has established friendly ties with more than 20 international partner hospitals across 13 countries on five continents. Luoyang Orthopedic Hospital of Henan Province

It has 7 national key experimental platforms represented by the State Key Laboratory of Kidney Diseases. The hospital is equipped with nearly 60,000 sets of sophisticated medical equipment worth nearly 7 billion RMB, including the world-leading 5th-generation CyberKnife, Da Vinci surgical robot, digital angiography machine, cyclotron, the world’s second ZAP accelerator, computed tomography therapy system, hyperbaric oxygen chamber, magnetic navigation interventional system, intraoperative radiotherapy system and cobalt-60 therapy unit.

Founded in 1918. Departments including Hematology, Orthopedics and Traumatology are at the top national level. It has achieved outstanding results in hematopoietic stem cell transplantation, diagnosis and treatment of bone tumors, and emergency and critical care.

Founded in 1956, it is a Grade A tertiary general hospital with orthopedics and burn medicine as key disciplines. Annual outpatient and emergency visits reach 3.0053 million, surgeries 90,400, and inpatient admissions 100,500. As the National Orthopedic Center, the hospital was the designated medical support hospital for the 2008 Beijing Olympic Games, the 2022 Beijing Winter Olympic Games and Winter Paralympic Games.

Founded in 1937. Its clinical capabilities in the fields of heart, liver, kidney, lung, digestive tract and panvascular diseases are at the top domestic and world-advanced level. The hospital is fully equipped with world-class diagnostic and therapeutic equipment including Da Vinci surgical robots, 3.0T high-field MRI, PET-CT, high-end DSA interventional systems and precision radiotherapy devices. More than 90 MDT teams have been established. Annual outpatient and emergency visits exceed 6.1 million, inpatient admissions over 280,000, and inpatient surgeries more than 210,000.